You have full text access to this OnlineOpen article

Attenuation of cardiac mitochondrial dysfunction by melatonin in septic mice

  1. Germaine Escames1,
  2. Luis C. López1,
  3. Francisco Ortiz1,
  4. Ana López1,
  5. José A. García1,
  6. Eduardo Ros2,
  7. Darío Acuña-Castroviejo1,3

Article first published online: 20 MAR 2007

DOI: 10.1111/j.1742-4658.2007.05755.x

Issue

FEBS Journal

FEBS Journal

Volume 274, Issue 8, pages 2135–2147, April 2007

Additional Information

How to Cite

Escames, G., López, L. C., Ortiz, F., López, A., García, J. A., Ros, E. and Acuña-Castroviejo, D. (2007), Attenuation of cardiac mitochondrial dysfunction by melatonin in septic mice. FEBS Journal, 274: 2135–2147. doi: 10.1111/j.1742-4658.2007.05755.x

Author Information

  1. 1

     Instituto de Biotecnología, Departamento de Fisiología, Universidad de Granada, Spain

  2. 2

     Servicio de Angiología y Cirugía Vascular, Hospital Universitario San Cecilio, Granada, Spain

  3. 3

     Servicio de Análisis Clínicos, Hospital Universitario San Cecilio, Granada, Spain

*D. Acuña-Castroviejo, Departamento de Fisiología, Facultad de Medicina, Avenida de Madrid 11, E-18012, Spain Fax: +34 958246295 Tel: +34 958246631 E-mail: dacuna@ugr.es

Publication History

  1. Issue published online: 20 MAR 2007
  2. Article first published online: 20 MAR 2007
  3. (Received 4 December 2006, revised 9 February 2007, accepted 23 February 2007)

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (724K)

References

  • 1
    Riedemann NC, Guo RF & Ward PA (2003) The enigma of sepsis. J Clin Invest 112, 460–467.
  • 2
    Court O, Kumar A, Parrillo JE & Kumar A (2002) Clinical review: myocardial depression in sepsis and septic shock. Crit Care 6, 500–508.
  • 3
    Levy RJ & Deutschman CS (2004) Evaluating myocardial depression in sepsis. Shock 22, 1–10.
  • 4
    Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R, Davies NA, Cooper CE & Singer M (2002) Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360, 219–223.
  • 5
    Callahan LA & Supinski GS (2005) Sepsis induces diaphragm electron transport chain dysfunction and protein depletion. Am J Respir Crit Care Med 172, 861–868.
  • 6
    Crouser ED (2004) Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome. Mitochondrion 4, 729–741.
  • 7
    Boczkowski J, Lisdero CL, Lanone S, Samb A, Carreras MC, Boveris A, Aubier M & Poderoso JJ (1999) Endogenous peroxynitrite mediates mitochondrial dysfunction in rat diaphragm during endotoxemia. FASEB J 13, 1637–1646.
  • 8
    Boveris A, Álvarez S & Navarro A (2002) The role of mitochondrial nitric oxide synthase in inflammation and septic shock. Free Radic Biol Med 33, 1186–1193.
  • 9
    Escames G, López LC, Tapias V, Utrilla P, Reiter RJ, Hitos AB, León J, Rodríguez MI & Acuña-Castroviejo D (2006) Melatonin counteracts inducible mitochondrial nitric oxide synthase-dependent mitochondrial dysfunction in skeletal muscle of septic mice. J Pineal Res 40, 71–78.
    Direct Link:
  • 10
    Massion PB, Feron O, Dessy C & Balligand JJ (2003) Nitric oxide and cardiac function: ten years after, and continuing. Circ Res 93, 388–398.
  • 11
    Escames G, León J, Macías M, Khaldy H & Acuña-Castroviejo D (2003) Melatonin counteracts lipopolysaccheride-induced expression and activity of mitochondrial nitric oxide synthase in rats. FASEB J 17, 932–934.
  • 12
    López LC, Escames G, Tapias V, Utrilla P, León J & Acuña-Castroviejo D (2006) Identification of an inducible nitric oxide synthase in diaphragm mitochondria from septic mice. Its relation with mitochondrial dysfunction and prevention by melatonin. Int J Biochem Cell Biol 38, 267–278.
  • 13
    Zanella B, Giordano E, Muscari C, Zini M & Guarnieri C (2004) Nitric oxide synthase activity in rat cardiac mitochondria. Basic Res Cardiol 99, 159–164.
  • 14
    Acuña-Castroviejo D, Escames G, López LC, Hitos AB & León J (2005) Melatonin and nitric oxide: two required antagonists for mitochondrial homeostasis. Endocrine 27, 159–168.
  • 15
    Lisdero CL, Carreras MC, Meulemans A, Melani M, Aubier M, Boczkowski J & Poderoso JJ (2004) The mitochondrial interplay of ubiquinol and nitric oxide in endotoxemia. Methods Enzymol 382, 67–81.
  • 16
    Kanai AJ, Pearce LL, Clemens PR, Birder LA, VanBibber MM, Choi SY, de Groat WC & Peterson J (2001) Identification of a neuronal nitric oxide synthase in isolated cardiac mitochondria using electrochemical detection. Proc Natl Acad Sci USA 98, 14126–11431.
  • 17
    Tatoyan A & Giulivi C (1998) Purification and characterization of a nitric oxide synthase from rat liver mitochondria. J Biol Chem 273, 11044–11048.
  • 18
    Álvarez S & Bóveris A (2004) Mitochondrial nitric oxide metabolism in rat muscle during endotoxemia. Free Radic Biol Med 37, 1472–1478.
  • 19
    Brown GC (2001) Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase. Biochim Biophys Acta 1504, 46–57.
  • 20
    Cadenas E, Poderoso JJ, Antunes F & Boveris A (2000) Analysis of the pathways of nitric oxide utilization in mitochondria. Free Radic Res 33, 747–756.
  • 21
    Piantadosi CA, Tatro LG & Whorton AR (2002) Nitric oxide and differential effects of ATP on mitochondrial permeability transition. Nitric Oxide 6, 45–60.
  • 22
    Poderoso JJ, Carreras MC, Lisdero C, Riobó N, Schöper F & Boveris A (1996) Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch Biochem Biophys 308, 89–95.
  • 23
    Albuszies G & Bruckner UB (2003) Antioxidant therapy in sepsis. Intensive Care Med 29, 1632–1636.
  • 24
    Acuña-Castroviejo D, Escames G, Carazo A, León J, Khaldy H & Reiter RJ (2002) Melatonin, mitochondrial homeostasis and mitochondrial-related diseases. Curr Top Med Chem 2, 133–151.
  • 25
    Acuña-Castroviejo D, Escames G, León J, Carazo A & Khaldy H (2003) Mitochondrial regulation by melatonin and its metabolites. Adv Exp Med Biol 527, 549–557.
  • 26
    Acuña-Castroviejo D, Martín M, Macías M, Escames G, León J, Khaldy H & Reitrer RJ (2001) Melatonin, mitochondria and cellular bioenergetics. J Pineal Res 30, 65–74.
    Direct Link:
  • 27
    León J, Acuña-Castroviejo D, Escames G, Tan DX & Reiter RJ (2005) Melatonin mitigates mitochondrial malfunction. J Pineal Res 38, 1–9.
    Direct Link:
  • 28
    León J, Acuña-Castroviejo D, Sainz RM, Mayo JC, Tan DX & Reiter RJ (2004) Melatonin and mitochondrial function. Life Sci 75, 765–790.
  • 29
    Crespo E, Macias M, Pozo D, Escames G, Martin M, Vives F, Guerreo JM & Acuña-Castroviejo D (1999) Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats. FASEB J 13, 1537–1546.
  • 30
    Bates TE, Loesch A, Burnstock G & Clark JB (1995) Immunocytochemical evidence for a mitochondrially located nitric oxide synthase in brain and liver. Biochem Biophys Res Commun 213, 896–900.
  • 31
    Brookes PS (2004) Mitochondrial nitric oxide synthase. Mitochondrion 3, 187–204.
  • 32
    Ghafourifar P & Cadenas E (2005) Mitochondrial nitric oxide synthase. Trends Pharmacol Sci 26, 190–195.
  • 33
    Elfering SL, Sarkela TM & Giulivi C (2002) Biochemistry of mitochondrial nitric-oxide synthase. J Biol Chem 277, 38079–38086.
  • 34
    Barth E, Radermacher P, Thiemermann C, Weber S, Georgieff M & Albuszies G (2006) Role of inducible nitric oxide synthase in the reduced responsiveness of the myocardium to catecholamines in a hyperdynamic, murine model of septic shock. Crit Care Med 34, 307–313.
  • 35
    Radi R, Cassina A, Hodara R, Quijano C & Castro L (2002) Peroxynitrite reactions and formation in mitochondria. Free Radic Biol Med 33, 1451–1464.
  • 36
    Kuzkaya N, Weissmann N, Harrison DG & Dikalov S (2003) Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem 278, 22546–22554.
  • 37
    Kobzik L, Stringer B, Balligand JL, Reid MB & Stamler JS (1995) Endothelial type nitric oxide synthase in skeletal muscle fibers: mitochondrial relationships. Biochem Biophys Res Commun 211, 375–381.
  • 38
    Kumagai Y, Kikushima M, Nakai Y, Shimojo N & Kunimoto M (2004) Neuronal nitric oxide synthase (nNOS) catalyzes one-electron reduction of 2,4,6-trinitrotoluene, resulting in decreased nitric oxide production and increased nNOS gene expression: implications for oxidative stress. Free Radic Biol Med 37, 350–357.
  • 39
    Lacza Z, Kozlov AV, Pankotai E, Csordás A, Wolf G, Redl H, Kollai M, Szabo C, Busija DW & Horn TF (2006) Mitochondria produce reactive nitrogen species via an arginine-independent pathway. Free Radic Res 40, 369–378.
  • 40
    Nohl H, Staniek K & Kozlov AV (2005) The existence and significance of a mitochondrial nitrite reductase. Redox Rep 10, 281–286.
  • 41
    Vyatkina G, Bhatia V, Gerstner A, Papaconstantinou J & Garg N (2004) Impaired mitochondrial respiratory chain and bioenergetics during chagasic cardiomyopathy development. Biochim Biophys Acta 1689, 162–173.
  • 42
    Pearce LL, Epperly MW, Greenberger JS, Pitt BR & Peterson J (2001) Identification of respiratory complexes I and III as mitochondrial sites of damage following exposure to ionizing radiation and nitric oxide. Nitric Oxide 5, 128–136.
  • 43
    Ataullakhanov FI & Vitvitsky VM (2002) What determines the intracellular ATP concentration. Biosci Rep 22, 501–511.
  • 44
    Saks V, Dzeja P, Schlattner U, Vendelin M, Terzic A & Wallimann T (2006) Cardiac system bioenergetics: metabolic basis of the Frank–Starling law. J Physiol 571, 253–273.
    Direct Link:
  • 45
    Supinski GS & Callahan LA (2006) Polyethylene glycol-superoxide dismutase prevents endotoxin induced cardiac dysfunction. Am J Respir Crit Care Med 173, 1240–1247.
  • 46
    Naqui A, Chance B & Cadenas E (1986) Reactive oxygen intermediates in biochemistry. Annu Rev Biochem 55, 137–166.
  • 47
    Fridovich I (1995) Superoxide radical and superoxide dismutases. Annu Rev Biochem 64, 97–112.
  • 48
    Szabó C (2003) Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett 140–141, 105–112.
  • 49
    Anderson MF & Sims NR (2002) The effects of focal ischemia and reperfusion on the glutathione content of mitochondria from rat brain subregions. J Neurochem 81, 541–549.
    Direct Link:
  • 50
    Antolín I, Rodríguez C, Sainz RM, Mayo JC, Uría H, Kotler ML, Rodríguez-Colunga MJ, Tolivia D & Menéndez-Peláez A (1996) Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes. FASEB J 10, 882–890.
  • 51
    Mayo JC, Sainz RM, Tan DX, Hardeland R, León J, Rodríguez C & Reiter RJ (2005) Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (aFMK) and (N1-acetyl-5-methxykynuramine (AMK), in macrophages. J Neuroimmunol 165, 139–149.
  • 52
    Tan DX, Manchester LC, Reiter RJ, Qi WB, Karbownik M & Calvo JR (2000) Significance of melatonin in antioxidative defense system: reactions and products. Biol Signals Recep 9, 137–159.
  • 53
    Martín M, Macías M, Escames G, León J & Acuña-Castroviejo D (2000) Melatonin but not vitamin C and E maintains glutathione homeostasis in t-butyl hydroperoxide-induced mitochondrial oxidative stress. FASEB J 14, 1677–1679.
  • 54
    Castillo C, Salazar V, Ariznavarreta C, Vara E & Tresguerres JA (2005) Effect of melatonin administration on parameters related to oxidative damage in hepatocytes isolated from old Wistar rats. J Pineal Res 38, 140–146.
    Direct Link:
  • 55
    Martín M, Macias M, León J, Escames G, Khaldy H & Acuña-Castroviejo D (2001) Melatonin increases the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria. Int J Biochem Cell Biol 1212, 1–10.
  • 56
    He L & Lemasters JJ (2002) Regulated and unregulated mitochondrial permeability transition pores: a new paradigm of pore structure and function? FEBS Lett 512, 1–7.
  • 57
    Kowaltowski AJ, Castilho RF & Vercesi AE (2001) Mitochondrial permeability transition and oxidative stress. FEBS Lett 495, 12–15.
  • 58
    Wu CC, Chiao CW, Hsiao G, Chen A & Yen MH (2001) Melatonin prevents endotoxin-induced circulatory failure in rats. J Pineal Res 30, 147–156.
    Direct Link:
  • 59
    Escames G, Acuña-Castroviejo D, López LC, Tan DX, Maldonado MD, Sánchez-Hidalgo M, León J & Reiter RJ (2006) The pharmacological utility of melatonin in the treatment of septic shock. J Pharm Pharmacol 58, 1153–1165.
    Direct Link:
  • 60
    Gitto E, Karbownik M, Reiter RJ, Tan DT, Cuzzocrea S, Chiurazzi P, Cordaro S, Corona G, Troimarchi G & Barberi I (2001) Effect of melatonin treatment in septic newborns. Pediatr Res 50, 756–760.
  • 61
    Wichterman KA, Baue AE & Chaudry IH (1980) Sepsis and septic shock − a review of laboratory models and a proposal. J Surg Res 29, 189–201.
  • 62
    Bredt DS & Snyder SH (1989) NO mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 86, 9030–9033.
  • 63
    Lowry OH, Rosenbrough NJ, Farr AL & Randall RJ (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193, 265–275.
  • 64
    Green LC, Ruiz de Luzuriaga K & Wagner DA (1981) Nitrate biosynthesis in man. Proc Natl Acad Sci USA 78, 7764–7768.
  • 65
    Barrientos A (2002) In vivo and in organello assessment of OXPHOS activities. Methods 26, 307–316.
  • 66
    Brusque AM, Borba Rosa R, Schuck PF, Dalcin KB, Ribeiro CA, Silva CG, Wannmacher CM, Dutra-Filho CS, Wyse AT, Briones P et al. (2002) Inhibition of the mitochondrial respiratory chain complex activities in rat cerebral cortex by methylmalonic acid. Neurochem Int 40, 593–601.
  • 67
    Taussky HH & Shorr E (1953) A microcolorimetric method for the determination of inorganic phosphorus. J Biol Chem 202, 675–685.
  • 68
    Manfredi G, Yang L, Gajewski CD & Mattiazzi M (2002) Measurements of ATP in mammalian cells. Methods 26, 317–326.
  • 69
    Monteiro P, Duarte AI, Moreno A, Gonçalves LM & Providencia LA (2003) Carvedilol improves energy production during acute global myocardial ischemia. Eur J Pharmacol 482, 245–253.
  • 70
    Pissarek M, Reinhardt R, Reichelt C, Manaenko A, Krauss G & Illes P (1999) Rapid assay for one-run determination of purine and pyrimidine mucleotide contents in neocortical slices and cell cultures. Brain Res Protoc 4, 314–321.
  • 71
    Krauss GJ, Pissarek M & Blasig I (1997) HPLC of nucleic acid components with volatile mobile phases: Part 2. Separations on polymeric supports. J High Resolut Chromatogr 20, 693–696.
    Direct Link:
  • 72
    Esterbauer H & Cheeseman KH (1990) Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186, 407–421.
  • 73
    Hissin PJ & Hilf R (1976) A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 74, 214–216.
  • 74
    Jaskot RH, Charlet EG, Grose EC, Grady MA & Roycroft JH (1983) An automatic analysis of glutathione peroxidase, glutathione-S-transferase, and reductase activity in animal tissue. J Anal Toxicol 7, 86–88.
View Full Article (HTML) Get PDF (724K)